0
0
Read Time:12 Second
Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated April 21, 2026, titled “Orbicular s Partner secures tentative U.S. ANDA approval for a generic version of Ozempic® (Semaglutide Injection), supported by OneSource as CDMO partner”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %